发明名称 |
Reduced volume formulation of glatiramer acetate and methods of administration |
摘要 |
A method for reducing frequency of relapses in a human patient afflicted with relapsing-remitting multiple sclerosis (RRMS) comprising administering to the patient 0.5 ml of an aqueous pharmaceutical solution of 20 mg glatiramer acetate and 20 mg mannitol. |
申请公布号 |
US9018170(B2) |
申请公布日期 |
2015.04.28 |
申请号 |
US201012948611 |
申请日期 |
2010.11.17 |
申请人 |
Teva Pharmaceutical Industries, Ltd. |
发明人 |
Altman Ayelet;Saltkill Doris;El-Gad Tomer;Tomlinson Dalton L. |
分类号 |
A61K38/07;A61K9/00;A61K38/16 |
主分类号 |
A61K38/07 |
代理机构 |
Cooper & Dunham LLP |
代理人 |
White John P.;Gershik Gary J.;Cooper & Dunham LLP |
主权项 |
1. An aqueous pharmaceutical solution which is 0.5 ml in volume and contains 20 mg glatiramer acetate and 20 mg mannitol in water for injection. |
地址 |
Petach-Tikva IL |